| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | receptor antagonist activity | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 2.93e-09 | 32 | 147 | 7 | GO:0048019 |
| GeneOntologyMolecularFunction | signaling receptor inhibitor activity | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 4.27e-08 | 46 | 147 | 7 | GO:0030547 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B ABCA2 ZGRF1 KIF4A ABCC11 ABCC9 ACSS2 DDX55 BCS1L MDN1 STARD9 ATP2C2 ERCC6L2 SHOC1 KIF4B ATP12A | 1.23e-05 | 614 | 147 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.56e-04 | 109 | 147 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | beta-adrenergic receptor activity | 3.20e-04 | 4 | 147 | 2 | GO:0004939 | |
| GeneOntologyBiologicalProcess | negative regulation of execution phase of apoptosis | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 1.80e-10 | 23 | 147 | 7 | GO:1900118 |
| GeneOntologyBiologicalProcess | regulation of execution phase of apoptosis | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 1.77e-08 | 42 | 147 | 7 | GO:1900117 |
| GeneOntologyBiologicalProcess | intracellular transport | MON2 KIF21B SMG1 VPS18 ABCA2 GBF1 COPG1 LRRK2 DERL2 XPO4 KIF4A NUP214 COG3 TEK THOC2 STAT3 ADRB2 MDN1 UBR5 AP5B1 NUP210 UHMK1 TACC1 LRBA TBC1D23 HPS5 VPS13B DOP1B | 2.13e-06 | 1496 | 147 | 28 | GO:0046907 |
| GeneOntologyBiologicalProcess | execution phase of apoptosis | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 1.24e-05 | 108 | 147 | 7 | GO:0097194 |
| GeneOntologyBiologicalProcess | behavior | ABCA2 ABL1 SLC4A7 LRRK2 MC4R DERL2 ACSS2 PIAS1 STAT3 CCND2 ADRB1 ADRB2 NRXN2 GLRB SLC4A10 CYP7B1 VPS13B CNP | 6.61e-05 | 891 | 147 | 18 | GO:0007610 |
| GeneOntologyBiologicalProcess | nuclear transport | SMG1 LRRK2 XPO4 NUP214 TEK THOC2 STAT3 MDN1 UBR5 NUP210 UHMK1 | 8.67e-05 | 378 | 147 | 11 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | SMG1 LRRK2 XPO4 NUP214 TEK THOC2 STAT3 MDN1 UBR5 NUP210 UHMK1 | 8.67e-05 | 378 | 147 | 11 | GO:0006913 |
| Domain | ARM-type_fold | MON2 SMG1 NCAPD3 GBF1 COPG1 NOC2L DOCK9 LRRK2 MROH5 XPO4 HEATR1 HUWE1 WDFY4 ITPR2 FOCAD PUM3 LRBA HECTD1 NIPBL | 1.21e-11 | 339 | 142 | 19 | IPR016024 |
| Domain | ARM-like | MON2 SMG1 NCAPD3 COPG1 LRRK2 MROH5 DOCK10 XPO4 HEATR1 HUWE1 WDFY4 CEP70 PUM3 LRBA HECTD1 NIPBL | 2.49e-10 | 270 | 142 | 16 | IPR011989 |
| Domain | - | MON2 NCAPD3 COPG1 LRRK2 MROH5 XPO4 HEATR1 WDFY4 PUM3 LRBA HECTD1 NIPBL | 1.32e-07 | 222 | 142 | 12 | 1.25.10.10 |
| Domain | Humanin | 6.49e-07 | 10 | 142 | 4 | IPR028139 | |
| Domain | Humanin | 6.49e-07 | 10 | 142 | 4 | PF15040 | |
| Domain | HEAT_REPEAT | 1.93e-04 | 70 | 142 | 5 | PS50077 | |
| Domain | Leu-rich_rpt | 2.32e-04 | 271 | 142 | 9 | IPR001611 | |
| Domain | Kinesin_motor_CS | 2.61e-04 | 41 | 142 | 4 | IPR019821 | |
| Domain | Sec7_N | 3.41e-04 | 4 | 142 | 2 | IPR032691 | |
| Domain | Sec7_N | 3.41e-04 | 4 | 142 | 2 | PF12783 | |
| Domain | - | 3.43e-04 | 44 | 142 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 3.43e-04 | 44 | 142 | 4 | PF00225 | |
| Domain | KISc | 3.43e-04 | 44 | 142 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 3.43e-04 | 44 | 142 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 3.43e-04 | 44 | 142 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 3.43e-04 | 44 | 142 | 4 | PS50067 | |
| Domain | Anion_exchange | 5.65e-04 | 5 | 142 | 2 | IPR001717 | |
| Domain | P-loop_NTPase | KIF21B ABCA2 ZGRF1 LRRK2 KIF4A ABCC11 ABCC9 DDX55 BCS1L PSTK NLRP9 MDN1 STARD9 ERCC6L2 KIF4B CNP | 7.31e-04 | 848 | 142 | 16 | IPR027417 |
| Domain | - | 7.92e-04 | 321 | 142 | 9 | 3.80.10.10 | |
| Domain | LRR_6 | 8.09e-04 | 55 | 142 | 4 | PF13516 | |
| Domain | DUF3398 | 8.44e-04 | 6 | 142 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 8.44e-04 | 6 | 142 | 2 | IPR021816 | |
| Domain | L_dom-like | 9.22e-04 | 328 | 142 | 9 | IPR032675 | |
| Domain | HECT | 1.10e-03 | 27 | 142 | 3 | PF00632 | |
| Domain | HECTc | 1.10e-03 | 27 | 142 | 3 | SM00119 | |
| Domain | HECT_dom | 1.10e-03 | 27 | 142 | 3 | IPR000569 | |
| Domain | HECT | 1.10e-03 | 27 | 142 | 3 | PS50237 | |
| Domain | ANION_EXCHANGER_2 | 1.18e-03 | 7 | 142 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 1.18e-03 | 7 | 142 | 2 | PS00219 | |
| Domain | LRR_1 | 1.45e-03 | 219 | 142 | 7 | PF00560 | |
| Domain | PH-BEACH_dom | 1.56e-03 | 8 | 142 | 2 | IPR023362 | |
| Domain | - | 1.56e-03 | 8 | 142 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.56e-03 | 8 | 142 | 2 | PS51783 | |
| Domain | - | 2.00e-03 | 9 | 142 | 2 | 3.40.1100.10 | |
| Domain | BEACH | 2.00e-03 | 9 | 142 | 2 | PS50197 | |
| Domain | Beach | 2.00e-03 | 9 | 142 | 2 | PF02138 | |
| Domain | - | 2.00e-03 | 9 | 142 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.00e-03 | 9 | 142 | 2 | SM01026 | |
| Domain | Band3_cytoplasmic_dom | 2.00e-03 | 9 | 142 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 2.00e-03 | 9 | 142 | 2 | PF07565 | |
| Domain | BEACH_dom | 2.00e-03 | 9 | 142 | 2 | IPR000409 | |
| Domain | PTrfase/Anion_transptr | 2.48e-03 | 10 | 142 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 2.48e-03 | 10 | 142 | 2 | IPR003020 | |
| Domain | Cyt_P450_E_grp-IV | 2.48e-03 | 10 | 142 | 2 | IPR002403 | |
| Domain | HCO3_cotransp | 2.48e-03 | 10 | 142 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 2.48e-03 | 10 | 142 | 2 | IPR011531 | |
| Domain | ADR_fam | 2.48e-03 | 10 | 142 | 2 | IPR002233 | |
| Domain | DHR-1_domain | 3.02e-03 | 11 | 142 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.02e-03 | 11 | 142 | 2 | PS51651 | |
| Domain | DHR_1 | 3.02e-03 | 11 | 142 | 2 | PS51650 | |
| Domain | DHR-2 | 3.02e-03 | 11 | 142 | 2 | PF06920 | |
| Domain | DOCK | 3.02e-03 | 11 | 142 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.02e-03 | 11 | 142 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.02e-03 | 11 | 142 | 2 | PF14429 | |
| Domain | DHR-2 | 3.02e-03 | 11 | 142 | 2 | IPR027357 | |
| Domain | ABC_transporter_CS | 3.98e-03 | 42 | 142 | 3 | IPR017871 | |
| Domain | Kinesin-like_fam | 4.25e-03 | 43 | 142 | 3 | IPR027640 | |
| Domain | LRR | 4.40e-03 | 201 | 142 | 6 | PS51450 | |
| Domain | AAA | 4.90e-03 | 144 | 142 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 4.90e-03 | 144 | 142 | 5 | IPR003593 | |
| Domain | ABC_tran | 5.80e-03 | 48 | 142 | 3 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.80e-03 | 48 | 142 | 3 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 6.14e-03 | 49 | 142 | 3 | PS00211 | |
| Domain | ATPase_P-typ_TM_dom | 6.42e-03 | 16 | 142 | 2 | IPR023298 | |
| Domain | - | 6.42e-03 | 16 | 142 | 2 | 1.20.1110.10 | |
| Domain | ABC_transporter-like | 6.50e-03 | 50 | 142 | 3 | IPR003439 | |
| Domain | ATPase_P-typ_cation-transptr_C | 7.24e-03 | 17 | 142 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 7.24e-03 | 17 | 142 | 2 | PF00689 | |
| Pubmed | Evidence for potential functionality of nuclearly-encoded humanin isoforms. | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 3.68e-14 | 13 | 148 | 7 | 19477263 |
| Pubmed | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 3.68e-14 | 13 | 148 | 7 | 12009529 | |
| Pubmed | MTRNR2L13 MTRNR2L12 MTRNR2L2 MTRNR2L3 MTRNR2L1 MTRNR2L11 MTRNR2L8 | 7.33e-14 | 14 | 148 | 7 | 11371646 | |
| Pubmed | AKAP6 SMG1 CASP8AP2 GBF1 DOCK9 DOCK10 ADGRA2 NRXN2 UBR5 CACNA1G HPS5 DOP1B | 2.70e-10 | 225 | 148 | 12 | 12168954 | |
| Pubmed | AKAP6 KIF21B SMG1 CASP8AP2 NCAPD3 ABCA2 XPO4 DDX55 ADGRA2 PLPPR4 NRXN2 HMGXB3 CACNA1G HPS5 EXOSC7 | 9.13e-09 | 529 | 148 | 15 | 14621295 | |
| Pubmed | MON2 KNTC1 SMG1 NCAPD3 COPG1 NOC2L PSMA6 DERL2 XPO4 PSMD4 HEATR1 HUWE1 COG3 THOC2 STAT3 PPM1G ITPR2 GGH MDN1 UBR5 NUP210 EIF2B3 PUM3 CNP | 1.06e-08 | 1440 | 148 | 24 | 30833792 | |
| Pubmed | 6.48e-08 | 10 | 148 | 4 | 23402768 | ||
| Pubmed | The human mitochondrial genome may code for more than 13 proteins. | 6.48e-08 | 10 | 148 | 4 | 25630734 | |
| Pubmed | Humanin peptide suppresses apoptosis by interfering with Bax activation. | 1.02e-07 | 11 | 148 | 4 | 12732850 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MON2 COPG1 XPO4 TMEM214 NUP214 HEATR1 STK11IP STAT3 GGH MDN1 DTWD2 UBR5 NUP210 PUM3 ZMYM1 HECTD1 | 1.56e-07 | 754 | 148 | 16 | 33060197 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 NCAPD3 GBF1 COPG1 PSMA6 XPO4 PSMD4 NUP214 HEATR1 HUWE1 PPM1G UBR5 NUP210 LPP EIF2B3 PIPSL HECTD1 CNP | 1.95e-07 | 974 | 148 | 18 | 28675297 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 ABCA2 ABL1 GBF1 ANKRD37 DOCK9 OBSCN NUP214 HUWE1 STK11IP ADGRA2 ITPR2 FOCAD TLNRD1 MDN1 EIF2B3 HMGXB3 LRBA HECTD1 | 2.62e-07 | 1105 | 148 | 19 | 35748872 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 NOC2L NUP214 HUWE1 DDX55 ITPR2 UBR5 NUP210 PUM3 HECTD1 EXOSC7 ANAPC4 | 4.49e-07 | 440 | 148 | 12 | 34244565 |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 28425671 | ||
| Pubmed | The central melanocortin system directly controls peripheral lipid metabolism. | 7.50e-07 | 5 | 148 | 3 | 17885689 | |
| Pubmed | COPG1 NOC2L KIF4A NUP214 HEATR1 HUWE1 THOC2 PPM1G MDN1 UBR5 NUP210 PUM3 HECTD1 NIPBL | 8.61e-07 | 653 | 148 | 14 | 22586326 | |
| Pubmed | MON2 KIF21B VPS18 SLC4A7 DERL2 XPO4 PSMD4 NUP214 HEATR1 DDX55 PIAS1 RLF TLNRD1 TINF2 UBR5 MTF1 PUM3 DNAJC24 HECTD1 NIPBL | 9.73e-07 | 1327 | 148 | 20 | 32694731 | |
| Pubmed | MON2 VPS18 SLC4A7 GBF1 TMEM214 COG3 STK11IP ITPR2 TACC1 LRBA VPS13B DOP1B | 1.85e-06 | 504 | 148 | 12 | 34432599 | |
| Pubmed | 2.61e-06 | 7 | 148 | 3 | 23362347 | ||
| Pubmed | GBF1 COPG1 PSMD4 NUP214 HEATR1 HUWE1 THOC2 STAT3 MDN1 NUP210 LRBA HECTD1 CNP | 3.75e-06 | 638 | 148 | 13 | 33239621 | |
| Pubmed | Humanin: a novel central regulator of peripheral insulin action. | 6.23e-06 | 9 | 148 | 3 | 19623253 | |
| Pubmed | 6.23e-06 | 9 | 148 | 3 | 20542501 | ||
| Pubmed | MON2 DOCK9 DOCK10 NUP214 FOCAD UBR5 STARD9 VPS13B SENP7 DOP1B | 1.05e-05 | 407 | 148 | 10 | 12693553 | |
| Pubmed | NCAPD3 ABCA2 GBF1 DOCK9 DERL2 DOCK10 KIF4A ASPHD2 HEATR1 HUWE1 DDX55 ITPR2 MDN1 UBR5 NUP210 LRBA CNP | 1.06e-05 | 1168 | 148 | 17 | 19946888 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PSMA6 HLCS KIF4A PSMD4 NUP214 HEATR1 THOC2 ZYX STAT3 BAZ1A LPP TACC1 LRBA NIPBL ANAPC4 | 1.16e-05 | 934 | 148 | 15 | 33916271 |
| Pubmed | MON2 NCAPD3 NUP214 HEATR1 HUWE1 STK11IP BCS1L PPM1G MDN1 DTWD2 NUP210 CNP | 1.19e-05 | 606 | 148 | 12 | 36538041 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | NCAPD3 VPS18 GBF1 PSMD4 TMEM214 HUWE1 COG3 STK11IP FOCAD GGH MDN1 DTWD2 SLC35B4 SLC4A10 LRBA ATP12A | 1.27e-05 | 1061 | 148 | 16 | 33845483 |
| Pubmed | Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma. | 1.32e-05 | 34 | 148 | 4 | 32842143 | |
| Pubmed | MON2 PIK3AP1 KNTC1 SLC4A7 HLCS KIF4A NUP214 HUWE1 ITPR2 LPP TACC1 ZMYM1 HECTD1 | 1.64e-05 | 733 | 148 | 13 | 34672954 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18534365 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22028912 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 1.80e-05 | 2 | 148 | 2 | 36482480 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17667029 | ||
| Pubmed | Enriched environment enhances β-adrenergic signaling to prevent microglia inflammation by amyloid-β. | 1.80e-05 | 2 | 148 | 2 | 30093491 | |
| Pubmed | Anti-β-adrenoceptors autoimmunity causing 'idiopathic' arrhythmias and cardiomyopathy. | 1.80e-05 | 2 | 148 | 2 | 22447021 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31107911 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 23318885 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22593095 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18851973 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19213958 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18305025 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 1.80e-05 | 2 | 148 | 2 | 30081192 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25000590 | ||
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 1.80e-05 | 2 | 148 | 2 | 31067151 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 27541735 | ||
| Pubmed | Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes. | 1.80e-05 | 2 | 148 | 2 | 21705675 | |
| Pubmed | A COPI coat subunit interacts directly with an early-Golgi localized Arf exchange factor. | 1.80e-05 | 2 | 148 | 2 | 19039328 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 8693001 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34642472 | ||
| Pubmed | Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. | 1.80e-05 | 2 | 148 | 2 | 15361874 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21573230 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24966659 | ||
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 1.80e-05 | 2 | 148 | 2 | 10559369 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19378229 | ||
| Pubmed | PIK3R6 Promotes Angiogenesis in Hepatocellular carcinoma by Activating STAT3 Signaling Pathway. | 1.80e-05 | 2 | 148 | 2 | 37708538 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 31620969 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20803192 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 34716504 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21565503 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 7583452 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24749907 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20374546 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 15861037 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19333138 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18540901 | ||
| Pubmed | Beta1-adrenergic receptors on immune cells impair innate defenses against Listeria. | 1.80e-05 | 2 | 148 | 2 | 17404268 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 7929562 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28487987 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16189366 | ||
| Pubmed | Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. | 1.80e-05 | 2 | 148 | 2 | 11942593 | |
| Pubmed | Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure. | 1.80e-05 | 2 | 148 | 2 | 15212591 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11502890 | ||
| Pubmed | STAT3 induces muscle stem cell differentiation by interaction with myoD. | 1.80e-05 | 2 | 148 | 2 | 19223199 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30668166 | ||
| Pubmed | Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias. | 1.80e-05 | 2 | 148 | 2 | 18479335 | |
| Pubmed | Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction. | 1.80e-05 | 2 | 148 | 2 | 19623647 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 16113068 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17515456 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11641423 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24708416 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 12244098 | ||
| Pubmed | β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype. | 1.80e-05 | 2 | 148 | 2 | 23894672 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 19633206 | ||
| Pubmed | Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. | 1.80e-05 | 2 | 148 | 2 | 16946993 | |
| Pubmed | Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study. | 1.80e-05 | 2 | 148 | 2 | 15342173 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20352314 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18253135 | ||
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 1.80e-05 | 2 | 148 | 2 | 31486502 | |
| Pubmed | Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentation. | 1.80e-05 | 2 | 148 | 2 | 20185685 | |
| Pubmed | Cloning and tissue-specific expression of mouse macrophage colony-stimulating factor mRNA. | 1.80e-05 | 2 | 148 | 2 | 3493488 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 21450827 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 30483153 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 22299391 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 7968380 | ||
| Pubmed | A physical/psychological and biological stress combine to enhance endoplasmic reticulum stress. | 1.80e-05 | 2 | 148 | 2 | 26391182 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 10773663 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18193079 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 18193078 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 11748583 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 17919552 | ||
| Interaction | GPR45 interactions | MON2 KNTC1 NCAPD3 ABCA2 GBF1 XPO4 HEATR1 COG3 STK11IP STAT3 MDN1 CNP | 1.18e-06 | 300 | 139 | 12 | int:GPR45 |
| Interaction | C3orf18 interactions | 1.33e-06 | 115 | 139 | 8 | int:C3orf18 | |
| Interaction | NPTN interactions | MON2 KNTC1 SMG1 GBF1 XPO4 HEATR1 HUWE1 COG3 FOCAD MDN1 DOP1B | 3.71e-06 | 278 | 139 | 11 | int:NPTN |
| Interaction | SCN2B interactions | 4.25e-06 | 95 | 139 | 7 | int:SCN2B | |
| Interaction | SLC15A3 interactions | MON2 SMG1 COPG1 DERL2 HEATR1 HUWE1 PPM1G ITPR2 NUP210 EIF2B3 | 5.30e-06 | 234 | 139 | 10 | int:SLC15A3 |
| Interaction | EPHA1 interactions | 5.50e-06 | 235 | 139 | 10 | int:EPHA1 | |
| Interaction | HLA-B interactions | 6.38e-06 | 239 | 139 | 10 | int:HLA-B | |
| Interaction | UNC93B1 interactions | MON2 NCAPD3 DERL2 XPO4 HEATR1 COG3 TLR8 ITPR2 GGH MDN1 NUP210 TLR3 EIF2B3 | 6.51e-06 | 417 | 139 | 13 | int:UNC93B1 |
| Interaction | COMTD1 interactions | 1.05e-05 | 200 | 139 | 9 | int:COMTD1 | |
| Interaction | OPALIN interactions | 1.50e-05 | 209 | 139 | 9 | int:OPALIN | |
| Interaction | PACC1 interactions | 1.88e-05 | 119 | 139 | 7 | int:PACC1 | |
| Interaction | FAM234A interactions | 2.72e-05 | 126 | 139 | 7 | int:FAM234A | |
| Interaction | GPR17 interactions | 2.76e-05 | 283 | 139 | 10 | int:GPR17 | |
| Interaction | PSMD8 interactions | 3.90e-05 | 182 | 139 | 8 | int:PSMD8 | |
| Interaction | EBAG9 interactions | MON2 SLC4A7 GBF1 COPG1 COG3 SLC35A4 SLC35B4 TACC1 LRBA VPS13B | 4.91e-05 | 303 | 139 | 10 | int:EBAG9 |
| Interaction | FLT3 interactions | 7.35e-05 | 318 | 139 | 10 | int:FLT3 | |
| Interaction | GJD3 interactions | MON2 SLC4A7 GBF1 COPG1 PSMD4 TMEM214 COG3 ITPR2 TACC1 LRBA VPS13B CNP | 7.45e-05 | 454 | 139 | 12 | int:GJD3 |
| Interaction | P2RY6 interactions | MON2 KNTC1 NCAPD3 NOC2L XPO4 HEATR1 THOC2 PPM1G MDN1 NUP210 EIF2B3 | 7.55e-05 | 385 | 139 | 11 | int:P2RY6 |
| Interaction | GPR182 interactions | MON2 KNTC1 NCAPD3 ABCA2 GBF1 DERL2 HEATR1 COG3 FOCAD MDN1 ATP12A DOP1B | 7.60e-05 | 455 | 139 | 12 | int:GPR182 |
| Interaction | SIAH2 interactions | 8.42e-05 | 104 | 139 | 6 | int:SIAH2 | |
| Interaction | KIF4A interactions | 1.04e-04 | 108 | 139 | 6 | int:KIF4A | |
| Interaction | MLNR interactions | 1.07e-04 | 68 | 139 | 5 | int:MLNR | |
| Interaction | DLK2 interactions | 1.08e-04 | 36 | 139 | 4 | int:DLK2 | |
| Interaction | NUP43 interactions | CASP8AP2 NOC2L TMEM214 NUP214 HEATR1 DDX55 RLF FSIP2 UBR5 BAZ1A ZMYM1 HPS5 NIPBL ANAPC4 | 1.09e-04 | 625 | 139 | 14 | int:NUP43 |
| Interaction | SIRT6 interactions | SMG1 NOC2L KIF4A NUP214 HUWE1 DDX55 PIAS1 ITPR2 UBR5 NUP210 PUM3 HECTD1 EXOSC7 ANAPC4 | 1.15e-04 | 628 | 139 | 14 | int:SIRT6 |
| Interaction | CA14 interactions | 1.31e-04 | 71 | 139 | 5 | int:CA14 | |
| Interaction | SEM1 interactions | 1.34e-04 | 162 | 139 | 7 | int:SEM1 | |
| Interaction | HS2ST1 interactions | 1.61e-04 | 117 | 139 | 6 | int:HS2ST1 | |
| Interaction | TNFSF13B interactions | 1.77e-04 | 119 | 139 | 6 | int:TNFSF13B | |
| Interaction | GYPA interactions | 2.08e-04 | 174 | 139 | 7 | int:GYPA | |
| Interaction | TPST2 interactions | 2.21e-04 | 124 | 139 | 6 | int:TPST2 | |
| Interaction | SUMO2 interactions | CASP8AP2 NCAPD3 COPG1 LRRK2 KIF4A NUP214 HUWE1 PIAS1 GGH MDN1 BAZ1A NIPBL SENP7 | 2.32e-04 | 591 | 139 | 13 | int:SUMO2 |
| Interaction | PSMD4 interactions | NCAPD3 ABL1 MYOD1 PSMA6 LRRK2 PSMD4 HUWE1 WDFY4 FBXO25 PIPSL | 2.41e-04 | 368 | 139 | 10 | int:PSMD4 |
| Interaction | P2RY8 interactions | 2.47e-04 | 179 | 139 | 7 | int:P2RY8 | |
| Interaction | EFNA4 interactions | 2.58e-04 | 239 | 139 | 8 | int:EFNA4 | |
| Interaction | HLA-DQB1 interactions | 2.59e-04 | 82 | 139 | 5 | int:HLA-DQB1 | |
| Interaction | DEPTOR interactions | 2.59e-04 | 82 | 139 | 5 | int:DEPTOR | |
| Interaction | TACSTD2 interactions | 2.74e-04 | 129 | 139 | 6 | int:TACSTD2 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 9.46e-05 | 46 | 94 | 4 | 622 | |
| GeneFamily | Adrenoceptors | 9.40e-04 | 9 | 94 | 2 | 169 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 9.40e-04 | 9 | 94 | 2 | 1230 | |
| GeneFamily | CD molecules|Toll like receptors | 1.17e-03 | 10 | 94 | 2 | 948 | |
| GeneFamily | ATP binding cassette subfamily C | 2.01e-03 | 13 | 94 | 2 | 807 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 3.46e-03 | 17 | 94 | 2 | 701 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 SMG1 CASP8AP2 NCAPD3 ZGRF1 KIF4A MCMDC2 HEATR1 HUWE1 ACSS2 FBXO25 MDN1 DTWD2 BAZ1A NUP210 EIF2B3 ERCC6L2 LRBA | 6.99e-06 | 820 | 139 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#1_top-relative-expression-ranked_1000 | PIK3AP1 CYP26B1 DOCK9 DOCK10 ABCC9 TEK WDFY4 ADRB2 TLR3 KLHL4 | 3.18e-05 | 303 | 139 | 10 | gudmap_developingKidney_e15.5_Endothelial cells_1000_k1 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.43e-10 | 188 | 149 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.83e-10 | 191 | 149 | 10 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.38e-08 | 186 | 149 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.13e-07 | 185 | 149 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.68e-07 | 135 | 149 | 7 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.72e-07 | 199 | 149 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-06 | 176 | 149 | 7 | 29b71369503719c74888cd356ceb6724cfdcabd9 | |
| ToppCell | C_00|World / shred on cell type and cluster | 2.45e-06 | 179 | 149 | 7 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-06 | 182 | 149 | 7 | b1e66ccd5f33b4801f1cafddf97f5fc0c6dba8d1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-06 | 184 | 149 | 7 | 282118f8221fa383ffb81dfb5798a0b7f065f911 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-06 | 189 | 149 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.63e-06 | 190 | 149 | 7 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.02e-06 | 193 | 149 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 4.02e-06 | 193 | 149 | 7 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.60e-06 | 197 | 149 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | distal-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.08e-06 | 200 | 149 | 7 | 7a355c3883fd409b2e0868164bb6e7ce4b745776 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.08e-06 | 200 | 149 | 7 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.39e-05 | 155 | 149 | 6 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 179 | 149 | 6 | 21736ae288ea6113e2a5604fbda338fc6b2b94a8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.65e-05 | 184 | 149 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 4.36e-05 | 190 | 149 | 6 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.62e-05 | 192 | 149 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.62e-05 | 192 | 149 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 192 | 149 | 6 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.62e-05 | 192 | 149 | 6 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.76e-05 | 193 | 149 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.76e-05 | 193 | 149 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.04e-05 | 195 | 149 | 6 | 83c125223e7ca0f08a31414b3a16347912564765 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-05 | 196 | 149 | 6 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.33e-05 | 197 | 149 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 5.33e-05 | 197 | 149 | 6 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.64e-05 | 199 | 149 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-05 | 200 | 149 | 6 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| Drug | isoxsuprine | 2.02e-05 | 9 | 144 | 3 | CID000003783 | |
| Drug | detomidine | 2.88e-05 | 10 | 144 | 3 | CID000056031 | |
| Drug | Carteolol | 3.97e-05 | 2 | 144 | 2 | DB00521 | |
| Drug | cicloprolol | 3.97e-05 | 2 | 144 | 2 | CID000146294 | |
| Drug | ferulinolol | 3.97e-05 | 2 | 144 | 2 | ctd:C112517 | |
| Drug | Timolol | 3.97e-05 | 2 | 144 | 2 | DB00373 | |
| Drug | Metoprolol | 3.97e-05 | 2 | 144 | 2 | DB00264 | |
| Drug | Oxprenolol | 3.97e-05 | 2 | 144 | 2 | DB01580 | |
| Drug | Betaxolol | 3.97e-05 | 2 | 144 | 2 | DB00195 | |
| Drug | Dihydroalprenolol | 3.97e-05 | 2 | 144 | 2 | ctd:D004082 | |
| Drug | Penbutolol | 3.97e-05 | 2 | 144 | 2 | DB01359 | |
| Drug | Pirbuterol | 3.97e-05 | 2 | 144 | 2 | DB01291 | |
| Drug | Metipranolol | 3.97e-05 | 2 | 144 | 2 | DB01214 | |
| Drug | Levobunolol | 3.97e-05 | 2 | 144 | 2 | DB01210 | |
| Drug | Nadolol | 3.97e-05 | 2 | 144 | 2 | DB01203 | |
| Drug | Acebutolol | 3.97e-05 | 2 | 144 | 2 | DB01193 | |
| Drug | KMUP 880602 | 3.97e-05 | 2 | 144 | 2 | ctd:C466918 | |
| Drug | Spirendolol | 3.97e-05 | 2 | 144 | 2 | CID000068857 | |
| Drug | Carteolol | 3.97e-05 | 2 | 144 | 2 | ctd:D002354 | |
| Drug | Dobutamine | 3.97e-05 | 2 | 144 | 2 | DB00841 | |
| Drug | Bisoprolol | 3.97e-05 | 2 | 144 | 2 | DB00612 | |
| Drug | LK 204-545 | 3.97e-05 | 2 | 144 | 2 | CID005311116 | |
| Drug | befunolol | 3.97e-05 | 2 | 144 | 2 | ctd:C006034 | |
| Drug | Salbutamol | 3.97e-05 | 2 | 144 | 2 | DB01001 | |
| Drug | Nebivolol | 3.97e-05 | 2 | 144 | 2 | DB04861 | |
| Drug | N-(4-(2-hydroxy-3-(2-methoxy-1-oxyethylaminobenzene)propoxy))benzaldehyde | 3.97e-05 | 2 | 144 | 2 | ctd:C435583 | |
| Drug | B 24-76 | 3.97e-05 | 2 | 144 | 2 | ctd:C058041 | |
| Drug | 2-chloroethylamine | 3.97e-05 | 2 | 144 | 2 | ctd:C010076 | |
| Drug | Sotalol | 1.19e-04 | 3 | 144 | 2 | DB00489 | |
| Drug | arbutamine | 1.19e-04 | 3 | 144 | 2 | ctd:C076559 | |
| Drug | N-(3-hydroxy-1-(naphthalen-1-yl)-1,8,11-trioxa-5-azatridecan-13-yl)-6-(2-(2-(4,4-difluoro-4,4a-dihydro-5-(thiophen-2-yl)-4-bora-3a,4a-diaza-s-indacene-3-yl)vinyl)phenoxyacetamido)hexanamide | 1.19e-04 | 3 | 144 | 2 | ctd:C568515 | |
| Drug | 3-iodopindolol | 1.19e-04 | 3 | 144 | 2 | CID000123825 | |
| Drug | p-azidobenzylcarazolol | 1.19e-04 | 3 | 144 | 2 | CID000133262 | |
| Drug | Bevantolol | 1.19e-04 | 3 | 144 | 2 | DB01295 | |
| Drug | Fenoterol | 1.19e-04 | 3 | 144 | 2 | DB01288 | |
| Drug | LCB 2183 | 1.19e-04 | 3 | 144 | 2 | CID000133046 | |
| Drug | U-43,465F | 1.19e-04 | 3 | 144 | 2 | CID000134388 | |
| Drug | Arbutamine | 1.19e-04 | 3 | 144 | 2 | DB01102 | |
| Drug | broxaterol | 1.19e-04 | 3 | 144 | 2 | ctd:C045916 | |
| Drug | pBABC | 1.19e-04 | 3 | 144 | 2 | CID000126676 | |
| Drug | EXP063 | 1.19e-04 | 3 | 144 | 2 | CID003037493 | |
| Drug | ICYP-azide-2 | 1.19e-04 | 3 | 144 | 2 | CID003036190 | |
| Drug | BAM-CYP | 1.19e-04 | 3 | 144 | 2 | CID000125252 | |
| Drug | butofilolol | 1.19e-04 | 3 | 144 | 2 | CID000068838 | |
| Drug | soquinolol | 1.19e-04 | 3 | 144 | 2 | CID000068811 | |
| Drug | CS 476 | 1.19e-04 | 3 | 144 | 2 | CID000100459 | |
| Drug | exaprolol | 1.19e-04 | 3 | 144 | 2 | CID000065484 | |
| Drug | Alprenolol | 1.19e-04 | 3 | 144 | 2 | DB00866 | |
| Drug | AHR-9377 | 1.19e-04 | 3 | 144 | 2 | CID000054961 | |
| Drug | dicyclopropyl ketoxime | 1.19e-04 | 3 | 144 | 2 | CID000015072 | |
| Drug | Oberadilol | 1.19e-04 | 3 | 144 | 2 | CID003047798 | |
| Drug | CGP-12177-NBD | 1.19e-04 | 3 | 144 | 2 | CID003081105 | |
| Drug | Bupranolol | 1.19e-04 | 3 | 144 | 2 | DB08808 | |
| Drug | p-azidoclonidine | 1.19e-04 | 3 | 144 | 2 | CID003035819 | |
| Drug | ICYP-azide-1 | 1.19e-04 | 3 | 144 | 2 | CID000133837 | |
| Drug | AC1L4W2Z | 1.19e-04 | 3 | 144 | 2 | CID000193350 | |
| Drug | Guanine Nucleotides | 1.19e-04 | 3 | 144 | 2 | ctd:D006150 | |
| Drug | bucindolol | 1.19e-04 | 3 | 144 | 2 | ctd:C024307 | |
| Drug | H 216/44 | 1.19e-04 | 3 | 144 | 2 | CID000130141 | |
| Drug | Iodocyanopindolol | 1.19e-04 | 3 | 144 | 2 | ctd:D020120 | |
| Drug | AC1L1TT8 | 1.19e-04 | 3 | 144 | 2 | CID000060729 | |
| Drug | ADATN | 1.19e-04 | 3 | 144 | 2 | CID000133861 | |
| Drug | resiquimod | 1.58e-04 | 17 | 144 | 3 | ctd:C402365 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.68e-04 | 183 | 144 | 7 | 7498_DN | |
| Drug | esmolol | 1.89e-04 | 18 | 144 | 3 | CID000059768 | |
| Drug | MK-936 | 2.23e-04 | 19 | 144 | 3 | CID000002262 | |
| Drug | v315 | 2.36e-04 | 4 | 144 | 2 | CID000053925 | |
| Drug | Labetalol | 2.36e-04 | 4 | 144 | 2 | DB00598 | |
| Drug | NHNPNBE | 2.36e-04 | 4 | 144 | 2 | CID006453817 | |
| Drug | eclanamine | 2.36e-04 | 4 | 144 | 2 | CID000051228 | |
| Drug | Tobanum | 2.36e-04 | 4 | 144 | 2 | CID000065814 | |
| Drug | flestolol | 2.36e-04 | 4 | 144 | 2 | CID000055884 | |
| Drug | DAPN | 2.36e-04 | 4 | 144 | 2 | CID000125184 | |
| Drug | SOM-1122 | 2.36e-04 | 4 | 144 | 2 | CID000068918 | |
| Drug | Pindolol | 2.36e-04 | 4 | 144 | 2 | DB00960 | |
| Drug | tienoxolol | 2.36e-04 | 4 | 144 | 2 | CID000065678 | |
| Drug | Alp-NBD | 2.36e-04 | 4 | 144 | 2 | CID000126953 | |
| Drug | i 583 | 2.36e-04 | 4 | 144 | 2 | CID000072881 | |
| Drug | cyanopindolol | 2.36e-04 | 4 | 144 | 2 | ctd:C047975 | |
| Drug | amosulalol | 2.36e-04 | 4 | 144 | 2 | ctd:C032473 | |
| Drug | acebutolol azide | 2.36e-04 | 4 | 144 | 2 | CID000133410 | |
| Drug | CGP 20712A | 2.36e-04 | 4 | 144 | 2 | ctd:C049763 | |
| Drug | iodoazidobenzylpindolol | 2.36e-04 | 4 | 144 | 2 | CID000132676 | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.41e-04 | 194 | 144 | 7 | 5056_UP | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.56e-04 | 196 | 144 | 7 | 4578_UP | |
| Disease | interstitial cystitis (is_implicated_in) | 6.21e-05 | 3 | 135 | 2 | DOID:13949 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | AKAP6 ABL1 MYOD1 OBSCN HLCS NUP214 COG3 TEK STAT3 NLRP9 CSF1 DNAJC24 LRBA NIPBL VPS13B | 1.24e-04 | 1074 | 135 | 15 | C0006142 |
| Disease | anogenital venereal wart (is_marker_for) | 2.25e-04 | 26 | 135 | 3 | DOID:11168 (is_marker_for) | |
| Disease | colorectal carcinoma (biomarker_via_orthology) | 5.71e-04 | 8 | 135 | 2 | DOID:0080199 (biomarker_via_orthology) | |
| Disease | Hyperoxaluria | 5.71e-04 | 8 | 135 | 2 | C0020500 | |
| Disease | adiponectin measurement | 5.73e-04 | 146 | 135 | 5 | EFO_0004502 | |
| Disease | congestive heart failure (implicated_via_orthology) | 8.79e-04 | 41 | 135 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 9.44e-04 | 42 | 135 | 3 | DOID:612 (is_implicated_in) | |
| Disease | lymphocyte count | PIK3AP1 ABL1 SLC4A7 GBF1 PCDHGA5 DOCK10 ITPR2 CCND2 FOCAD SLC9A4 ADRB1 CSF1 NRXN2 LPP ERCC6L2 IL2 | 1.10e-03 | 1464 | 135 | 16 | EFO_0004587 |
| Disease | HIV Infections | 1.31e-03 | 103 | 135 | 4 | C0019693 | |
| Disease | HIV Coinfection | 1.31e-03 | 103 | 135 | 4 | C4505456 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.33e-03 | 12 | 135 | 2 | DOID:3319 (is_marker_for) | |
| Disease | Cardiomyopathy, Dilated | 1.39e-03 | 48 | 135 | 3 | C0007193 | |
| Disease | Fibrosis | 1.57e-03 | 50 | 135 | 3 | C0016059 | |
| Disease | Cirrhosis | 1.57e-03 | 50 | 135 | 3 | C1623038 | |
| Disease | cryptococcosis | 2.10e-03 | 15 | 135 | 2 | EFO_0007229 | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 2.10e-03 | 15 | 135 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | anemia (implicated_via_orthology) | 2.10e-03 | 15 | 135 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | asthma, Eczema, allergic rhinitis | 2.35e-03 | 121 | 135 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | creatine kinase measurement | 2.53e-03 | 59 | 135 | 3 | EFO_0004534 | |
| Disease | platelet component distribution width | VPS18 SLC4A7 DOCK9 LRRK2 DOCK10 ADRB1 MTF1 SLC35B4 LPP EIF2B3 | 2.54e-03 | 755 | 135 | 10 | EFO_0007984 |
| Disease | Obesity | 2.58e-03 | 205 | 135 | 5 | C0028754 | |
| Disease | Acute Myeloid Leukemia, M1 | 2.65e-03 | 125 | 135 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.65e-03 | 125 | 135 | 4 | C1879321 | |
| Disease | Acute myeloid leukemia | 2.70e-03 | 17 | 135 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.70e-03 | 17 | 135 | 2 | 601626 | |
| Disease | celiac disease | 2.73e-03 | 126 | 135 | 4 | EFO_0001060 | |
| Disease | squamous cell carcinoma (is_implicated_in) | 3.03e-03 | 18 | 135 | 2 | DOID:1749 (is_implicated_in) | |
| Disease | Congenital hernia of foramen of Morgagni | 3.38e-03 | 19 | 135 | 2 | C0265699 | |
| Disease | Congenital hernia of foramen of Bochdalek | 3.38e-03 | 19 | 135 | 2 | C0265700 | |
| Disease | Neoplasms, Experimental | 3.47e-03 | 66 | 135 | 3 | C0027659 | |
| Disease | asthma, age at onset | 4.10e-03 | 70 | 135 | 3 | EFO_0004847, MONDO_0004979 | |
| Disease | Congenital diaphragmatic hernia | 4.12e-03 | 21 | 135 | 2 | C0235833 | |
| Disease | haptoglobin measurement | 4.12e-03 | 21 | 135 | 2 | EFO_0004640 | |
| Disease | hepatitis B (is_marker_for) | 4.12e-03 | 21 | 135 | 2 | DOID:2043 (is_marker_for) | |
| Disease | stomach cancer (is_marker_for) | 4.18e-03 | 142 | 135 | 4 | DOID:10534 (is_marker_for) | |
| Disease | Crohn's disease | 4.28e-03 | 441 | 135 | 7 | EFO_0000384 | |
| Disease | respiratory system disease | 4.50e-03 | 145 | 135 | 4 | EFO_0000684 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ICLSESDKTAVLTLI | 596 | O75410 | |
| SVDVLCVTASIETLC | 136 | P08588 | |
| SIDVLCVTASIETLC | 111 | P07550 | |
| LALCLSSDLKSLSVV | 206 | Q9UJX5 | |
| STIDDIVLTILLCEV | 126 | Q7RTX7 | |
| ILLAESLIHDCTFIT | 296 | Q96PE1 | |
| ELEHSICLLSLTDSS | 246 | Q9Y276 | |
| LLESAELTTFSCSLL | 601 | Q8IYT2 | |
| LESLTRSTLLCLSAI | 1111 | O60706 | |
| ERILDSSCSLLITTD | 201 | Q9NR19 | |
| LSTLECAAVALSILE | 221 | Q8NBA8 | |
| EDLSLFLSTRCVVVL | 56 | Q6ZUJ8 | |
| CVSSILLEDLAVSLT | 1431 | Q9UKL3 | |
| ASSVFILSELLKLCE | 916 | O75185 | |
| SLDLDSCTLSEILRL | 541 | Q9NRL2 | |
| SLECLSLLVASDAQI | 76 | Q7Z713 | |
| FSCLLLVISEIDLSV | 6 | S4R3Y5 | |
| EVILTSLTSSISEDC | 346 | Q9Y5G8 | |
| IILSSLLQSCDLEVA | 601 | Q15397 | |
| LSVDLILRCVSDESL | 756 | Q14571 | |
| VLDELTLCTTDLEIQ | 196 | Q7Z3Y9 | |
| TLCTTDLEIQCETLS | 201 | Q7Z3Y9 | |
| FLLCTILTLSEQESV | 11 | A0A2R8YFM6 | |
| SSLTCDALTELLAKI | 221 | P30279 | |
| VLCLATVLTSLEGLS | 1491 | Q8TEM1 | |
| VSLISCDTCSLIIEL | 131 | Q6P3W2 | |
| LCLLSLTDLALSSTT | 66 | Q9H346 | |
| CILITDSTLIQLSIH | 296 | Q9UKC9 | |
| LTATALETADLAELC | 21 | Q5SZI1 | |
| STLAQLLLDKDCTVL | 46 | Q9NU22 | |
| SSSTINTLLTLLDCL | 46 | O75409 | |
| EDCLDILIITSDTLL | 341 | Q4G0Z9 | |
| FSCLLLSTSEIDLPV | 6 | P0CJ68 | |
| FSCLLLSTSEIDLPV | 6 | P0CJ69 | |
| FSCLLLSTSEIDLSV | 6 | P0CJ70 | |
| LEAVETLGSTSIICS | 376 | P54707 | |
| LDLVSALATLAACLV | 6 | Q9NR63 | |
| DLVCALSTLQTDTLL | 1721 | Q9Y3R5 | |
| DLAELTTLCLELNVL | 736 | Q9UPZ3 | |
| TDNCLLLVIATRESI | 211 | P50747 | |
| LDLASCVRSLDVLVL | 156 | Q8NHQ9 | |
| TSIDDDILASPLLTC | 1346 | Q5CZC0 | |
| FSCLLLSTSEIDLPV | 6 | P0CJ75 | |
| TLTSEELSQLQELLC | 851 | Q12766 | |
| STIAECIVNTLLTTL | 356 | Q9HCI6 | |
| SLLALTDLGLCVSTL | 76 | Q9H341 | |
| VSSLDCLSSIVERIS | 246 | P15172 | |
| VISSCSLAEARLLLD | 1021 | O75037 | |
| VLRLSSCSLVTEDVA | 426 | Q6UY01 | |
| SCSLVTEDVALLASV | 431 | Q6UY01 | |
| VLITCASLVICSISS | 281 | Q96J66 | |
| CDIVSSLSELLEIQL | 1391 | Q6KC79 | |
| VLLSAETTATTLLAD | 1346 | Q9P2S2 | |
| IDSLTSILADLECSS | 121 | Q93052 | |
| DEIDLTICSTLLAFI | 491 | P50851 | |
| SALSCLALLTETIFL | 311 | Q5S007 | |
| SDLESLCNALLKTTI | 911 | P35658 | |
| DSVSVLVLRCLTEAL | 381 | P50748 | |
| DLLQDLSSTLCILIR | 171 | Q8TCJ0 | |
| VLSLASECTTLAAEL | 306 | P48167 | |
| AEVAATSLLDTLVLL | 71 | Q2VPB7 | |
| SLLVTECEIFLSLLV | 326 | Q7Z3U7 | |
| TSVSLALATAECLLL | 101 | Q8NG92 | |
| LQEEACSLASLLVSV | 216 | Q15024 | |
| LLSILQRSSESELCI | 3226 | Q7Z6Z7 | |
| SAIQLVSCLSETTVL | 256 | Q9Y3T9 | |
| VSCLSETTVLAAVLR | 261 | Q9Y3T9 | |
| TIESLLAAACLLQLT | 251 | Q9C0H6 | |
| FSCLLLLISEIDLSV | 6 | S4R3P1 | |
| LITLDNDCEVLTTLT | 536 | A2A3N6 | |
| TLILILELCSSEELL | 6536 | Q5VST9 | |
| LELSCSDISVSTVVL | 181 | Q8WZ92 | |
| VLVLSCDLITDVALH | 101 | Q9NR50 | |
| CDTTAVITVACLLVL | 56 | Q6ICH7 | |
| DSSLEICVESLSSLL | 181 | Q9ULT8 | |
| LLSCIALSLALVTNS | 6 | P60568 | |
| NIATEVCLTILDLLS | 1481 | Q96BY6 | |
| LLEANIATEVCLTAL | 1391 | Q9BZ29 | |
| IATEVCLTALDTLSL | 1396 | Q9BZ29 | |
| LLVCLLASRSITEEV | 21 | P09603 | |
| LTSEIVSEPSCSLAL | 1986 | O43497 | |
| LQELLELDSSSSLCV | 506 | Q8NHQ1 | |
| ELDSSSSLCVLVSTV | 511 | Q8NHQ1 | |
| SLLISGECLLTATDT | 141 | Q92820 | |
| IEDLCSLTSQSLPIE | 61 | Q96JB2 | |
| VLTDTTAELAVSLLL | 106 | Q9UBQ7 | |
| VVLDSTEALCLAISR | 1031 | P00519 | |
| VASCLLVSDTSTELS | 1261 | Q9BZC7 | |
| CLVTESSVLATLTVV | 1131 | P08519 | |
| DTVATLLECKTLFIL | 41 | P09543 | |
| FSCLLLSTSEIDLPV | 6 | P0DMP1 | |
| SSLLASICSLLSIAV | 131 | P32245 | |
| LSLDALLTVIDSTEA | 576 | Q92538 | |
| LTEKTVLVALDTVSC | 176 | O95239 | |
| LTEKTVLVALDTVSC | 176 | Q2VIQ3 | |
| LSLDQVCSLISSDKL | 191 | Q9UH77 | |
| LDSLICLESSIFEAL | 346 | O75881 | |
| LGSALLCIAEVTSTL | 1711 | Q9H583 | |
| LCIAEVTSTLEALAI | 1716 | Q9H583 | |
| SCIAEDVIIVTSSLT | 96 | Q9Y678 | |
| LSKLTDLAVIETLCE | 1501 | Q5T890 | |
| TTACVLTTAAVQLEL | 21 | Q9GZP9 | |
| LITLANDCEVLTTLT | 51 | P55036 | |
| IILSLLVATFTECTS | 461 | Q13183 | |
| LSCLDSITEQSSILD | 2511 | Q6ZTR5 | |
| LQILSSTALEDCISV | 356 | Q5VW36 | |
| SLLETLTILRLSFCT | 156 | O60412 | |
| TSHLVLTTLLACLQE | 841 | Q6ZUA9 | |
| LICSRSLQALEELLS | 136 | Q8N1F8 | |
| SESALLELPLITCES | 476 | Q9BQF6 | |
| SFLCIVLVATDASSL | 701 | Q9Y6M7 | |
| TTECASLTVTLVVTL | 261 | Q969S0 | |
| LCLSDLSLLSTDSEL | 336 | Q14872 | |
| PELVSASVCSALLLE | 161 | Q5UE93 | |
| LLSSIVEELLDQCLA | 471 | O15355 | |
| SLSLASVIISALCTL | 2761 | Q96Q15 | |
| LLLVALECSEASSDL | 16 | Q6AI14 | |
| VTIRDVLLTCSLDTA | 666 | Q5VXU9 | |
| CVLTGAALTITDSEI | 511 | Q9BZQ2 | |
| LVLLASVLCFTSSVD | 236 | Q8NG04 | |
| VALGISSLDCVLDLT | 2351 | Q9P2P6 | |
| DSEIATTSLRVSLLC | 321 | O75925 | |
| DISRSLIALLCSTLL | 191 | Q8NH09 | |
| LSSSTLTLTEEELCI | 1756 | Q13023 | |
| DCLVSLVTSVTNVDL | 491 | Q13705 | |
| CLELTVTSASESILE | 471 | P42695 | |
| ISEVLLCSKSLSLLD | 791 | Q7RTR0 | |
| LCSTALITDIIQLST | 186 | Q7Z2D5 | |
| ETAITCLSTVLSIDF | 196 | P60900 | |
| SLELTTCVSDVTAVI | 816 | Q9NR97 | |
| SLTEKLCLELANTSI | 236 | O15455 | |
| TVQTLACSILTALLS | 151 | Q9C0E2 | |
| TEVILSCLLSITDQV | 476 | Q8NI27 | |
| ILLCEISTLTELNLS | 316 | Q6ZVD8 | |
| LTDLDLSSLCSLEQL | 451 | Q6ZVD8 | |
| LSCFELLLSVSESEL | 131 | Q13129 | |
| TSTVCLAVLLAAKEL | 266 | Q9H2B4 | |
| CDASLIVTEELHLIT | 426 | P40763 | |
| SLCSSVITIGDLVLD | 381 | Q9BSI4 | |
| CASEASLEVTDLLLT | 231 | Q8IV42 | |
| LLLLADRVEAVCTLT | 336 | Q9P253 | |
| TATLCIILVATDASS | 601 | Q6U841 | |
| DLSQALCLAISVSEI | 311 | Q9NUY8 | |
| LSSLTECLTVDPLSA | 386 | Q6NUQ4 | |
| SELQSLLIATTCLRE | 216 | Q6ZS81 | |
| VSLCPDDLSLVVSTE | 1111 | Q6ZS81 | |
| SLVELGDLVVSLTEC | 111 | Q9H1K6 | |
| SSAVLLTELTKLLLC | 51 | Q96G79 | |
| SLPLVSDAETSLTCI | 31 | Q02763 | |
| LLTLDCVDDTLIVLA | 216 | Q8TEA7 | |
| CISTVTAEDLLRSSI | 1891 | Q7Z7G8 | |
| SLCEHSTALDSLEIL | 831 | Q86YA3 | |
| VSSIDLEIDSLSSLL | 141 | Q15942 | |
| SLLVSLIAAIVLSCD | 141 | Q9NYW2 | |
| IFSLSSKIEAILECL | 886 | Q5SVZ6 | |
| SRCLLLELLDVSVSE | 106 | Q8TAS1 | |
| LEFSTTSVITECLIS | 141 | Q9NWH7 | |
| CTADILLLDTLLGTL | 1391 | O95071 |